Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    The 5 Stocks Set To Dominate 2025

    May 28, 2025

    Top Graphene Stocks For 2025

    December 18, 2024

    Don’t Miss Out: These 5 Trump-Boosted Stocks Could Transform Your Portfolio!

    October 31, 2024
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Market MonitorsMarket Monitors
    • Home
    • Market News
      1. Company News
      2. Economic Updates
      3. Market Trends
      4. View All

      Adobe (ADBE) Surpasses Q3 2024 Expectations with Remarkable Earnings

      September 13, 2024

      DJT Stocks Tumble After Trump’s Debate with VP Harris

      September 12, 2024

      Sony Redefines Gaming: PS5 Pro Release Date Set for November (SNE)

      September 11, 2024

      DWAC Stock Soars 7% on Tight Trump vs. Harris Poll

      September 10, 2024

      Australia Targets Big Tech: New Misinformation Fines Could Exceed 5% of Annual Revenue

      September 13, 2024

      JPMorgan’s Latest Economic Forecast and Its Impact on the Fed’s Next Move

      September 12, 2024

      Will Today’s Inflation Report Change the Market Game?

      September 11, 2024

      Optimistic Outlook: Fed’s Soft Landing Strategy Might Be Working

      September 10, 2024

      Tech Renaissance Drives Market: Nvidia (NVDA), Apple (AAPL) and More In Spotlight

      September 13, 2024

      How Kamala Harris’s Debate Triumph (and $47M Fundraising) Can Impact Your Investments

      September 13, 2024

      Is NVDA’s Surge the Key to Understanding Today’s Market Trends?

      September 13, 2024

      MTV VMAs 2024 Embrace AI-Powered Shopping: Experience Fashion Like Never Before with PARA

      September 11, 2024

      Tech Renaissance Drives Market: Nvidia (NVDA), Apple (AAPL) and More In Spotlight

      September 13, 2024

      Australia Targets Big Tech: New Misinformation Fines Could Exceed 5% of Annual Revenue

      September 13, 2024

      How Kamala Harris’s Debate Triumph (and $47M Fundraising) Can Impact Your Investments

      September 13, 2024

      Adobe (ADBE) Surpasses Q3 2024 Expectations with Remarkable Earnings

      September 13, 2024
    • Stock Watchlists
      1. Best AI Stocks
      2. Best Income Stocks
      3. Best Value Stocks
      4. View All

      5 Must-Buy AI Stocks for Investor’s Long-Term Payoff & Potential 24% Gains

      August 20, 2024

      3 AI-Powered Healthcare Stocks to Make You Rich in 2023!

      August 20, 2024

      3 Explosive Stocks Chosen by Gemini AI for Massive Gains in 2024!

      August 19, 2024

      Top 3 AI Stocks That Could Deliver Massive Gains Over Nvidia

      August 19, 2024

      5 Mind-Blowing Reasons to Bet Big on GM Right Now!

      September 4, 2024

      5 High-Performing Utilities Stocks Poised for Big Gains—Don’t Miss Out!

      September 2, 2024

      Discover 7 Insurance Stocks Ready to Explode – Don’t Miss Out on These Market Winners

      August 27, 2024

      Top 6 Factors You Need to Consider Before Buying or Selling P&G Stock!

      August 26, 2024

      5 Stocks Set to Soar: Alcoa and Other Contrarian Opportunities

      September 4, 2024

      5 Reasons AstraZeneca Could Skyrocket: Is It the Ultimate GARP Investment?

      September 3, 2024

      4 Media Stocks Ready to Skyrocket: Expert Predictions and Price Targets Revealed

      September 2, 2024

      5 Must-Buy Stocks with High Operating Margins for Max Profit Potential

      September 2, 2024

      Don’t Miss Out: These 5 Trump-Boosted Stocks Could Transform Your Portfolio!

      October 31, 2024

      Ride the AI Boom: 5 Nuclear Stocks Primed for Explosive Growth – Up to 13.7% Gains!

      October 19, 2024

      Netflix Explodes Higher as Markets Soar to New Heights

      October 18, 2024

      Wall Street Notches Another Record Close, But Is The Writing on the Wall for Tech?

      October 17, 2024
    • Expert Analysis
    Market MonitorsMarket Monitors
    Home»Stock Watchlists»Growth Stocks»Ride the Earnings Wave: 5 Unstoppable Stocks Including KNSY and MIL with Enormous Potential
    Growth Stocks

    Ride the Earnings Wave: 5 Unstoppable Stocks Including KNSY and MIL with Enormous Potential

    Uncover top picks set for explosive earnings growth. Don’t miss these market winners ready to deliver huge returns!
    Stock PickerBy Stock PickerAugust 22, 2024No Comments7 Mins Read
    Stocks
    StockPrice52 Week RangeMarketcapEPSDividend YieldChart (24H)SectorEmployeesLast Updated

    Investors, listen up. Finding stocks that outperform the market based on solid financial metrics can feel like mining for gold. But today, we’ve struck it rich. We’re diving deep into five outstanding stocks riding high on earnings momentum, and these aren’t just any stocks—they’re top picks from Louis Navellier’s Portfolio Grader.

    Editor's Note: Analysis and insight for this article were originally sourced from our friends at InvestorPlace

    Kensey Nash (NASDAQ: KNSY)

    Overview

    Kensey Nash is a pioneering company specializing in the development, manufacturing, and processing of resorbable biomaterials products. These advanced materials are essential in the medical devices market, an industry showing no signs of slowing down.

    Investment Appeal

    What really draws us to Kensey Nash? It earns an “A” in Operating Margin Growth, confirming its ability to generate increasing revenue from its operations efficiently. Kensey’s impressive grading on Portfolio Grader, particularly in operating margin metrics, signifies highly efficient management processes and robust profit margins. Advanced biomaterials are crucial in medical technology, contributing significantly to their earnings potential.

    Relevance

    The company’s advanced biomaterials technology aligns perfectly with the burgeoning medical devices market. As the sector grows, Kensey Nash is poised to capture a considerable share, driving continued revenue growth. If you’re aiming for a stock built on a foundation of efficiency and innovation, Kensey Nash is your ticket.

    Analyst Ratings and Forecasts:

    Metric Value
    Consensus Rating Overweight
    Average Price Target $343.67
    Potential Gain 14.1%
    Number of Ratings 6

    Summary of Analysts’ Outlook:
    Analysts have a bullish outlook on Kinsale Capital Group, Inc., with a consensus rating of Overweight. The average price target suggests a potential gain of 14.1% from the current price. Most analysts believe the company’s strong financial performance, expanding margins, and growing premiums will drive future growth.

    For more information, get Portfolio Grader’s complete analysis of KNSY stock

    MFC Industrial (NYSE: MIL)

    Overview

    MFC Industrial is an established global player in the supply and distribution of essential commodities and materials. Its extensive network and broad range of products place it at the heart of global trade and commerce.

    Investment Appeal

    Receiving stellar “A”s in Earnings Growth, Cash Flow, and Operating Margin Growth, MFC Industrial’s financial health is nothing short of impressive. This trifecta of strong metrics signals robust operational success and financial stability. It means MIL’s business model is not only operationally strong but also exhibits substantial earnings resilience and cash flow generation.

    Relevance

    The global marketplace for commodities is vast and growing. MFC Industrial’s strategic positioning in this space offers immense upside potential. For those eyeing the industrial and resource sectors, MFC Industrial represents a solid, lucrative investment candidate.

    Analyst Ratings and Forecasts:

    Metric Value
    Consensus Rating Buy
    Average Price Target ₹34.50 (INR)
    Potential Gain 24.1%
    Number of Ratings 13

    Summary of Analysts’ Outlook:
    Analysts have a bullish outlook on MFC Industrial, with a consensus “Buy” rating. The average price target of ₹34.50 suggests a potential gain of 24.1% from the current price. Most analysts believe that the company’s strong financial performance, improving operating margins, and growth initiatives will drive its stock price upward.

    For more information, get Portfolio Grader’s complete analysis of MIL stock

    Alon USA Energy (NYSE: ALJ)

    Overview

    Alon USA Energy operates as an independent refiner and marketer of petroleum products across various regions of the United States. It’s a key player in the energy sector, balancing supply with growing energy demands.

    Investment Appeal

    Alon earns top marks in Earnings Growth, Analyst Earnings Revisions, and Equity. These accolades illustrate not just past performance but potential future gains, making it a jewel within the energy market. Alon’s strategic geographical footprint enhances its efficiency and market penetration, ensuring sustained operational performance.

    Relevance

    Strategic geographic operations give Alon a significant competitive edge. Consistent earnings growth and positive analyst revisions are clear indicators of its robust market positioning. Alon USA Energy stands out as a strong choice in an industry characterized by its volatility.

    Analyst Ratings and Forecasts:

    Metric Value
    Consensus Rating Hold
    Average Price Target $1.25
    Potential Gain 25.0%
    Number of Ratings 2

    Summary of Analysts’ Outlook:
    The limited analyst coverage suggests a neutral outlook for Alon USA Energy, with a consensus rating of “Hold”. The average price target of $1.25 implies a potential gain of 25.0% from the current price. However, please note that the low number of ratings and the limited coverage may not provide a comprehensive view of the stock’s prospects.

    For more information, get Portfolio Grader’s complete analysis of ALJ stock

    Amedisys (NASDAQ: AMED)

    Overview

    Amedisys is a major player in home health care and hospice services, serving various communities across the United States. With an aging population, the demand for its services is on a steady rise.

    Investment Appeal

    Amedisys secures “A”s in Earnings Surprises and Cash Flow, showcasing its capability to manage finances adeptly and exceed market expectations regularly. Superior cash flow positions Amedisys to not only survive but thrive during financial downturns and health crises.

    Relevance

    The growth trajectory in home health care demand is hard to ignore. Amedisys’ strong financial performance and operational excellence place it at the forefront of this expanding industry. For investors focusing on the health care sector, Amedisys presents a compelling opportunity.

    Analyst Ratings and Forecasts:

    Metric Value
    Consensus Rating Overweight
    Average Price Target $244.50
    Potential Gain 14.1%
    Number of Ratings 13

    Summary of Analysts’ Outlook:
    Analysts have a positive outlook on Amedisys Inc., with a consensus rating of Overweight. The average price target of $244.50 suggests a potential gain of 14.1% from the current price. Overall, analysts believe that the company’s strong financial performance, growth initiatives, and industry trends will drive its stock price higher.

    For more information, get Portfolio Grader’s complete analysis of AMED stock

    URS Corp. (NYSE: URS)

    Overview

    URS Corp. offers diversified engineering, construction, and technical services across numerous market segments including power, infrastructure, federal, industrial, and commercial sectors. Its broad service offering positions it as a key player in these critical areas.

    Investment Appeal

    URS shines with “A”s in Earnings Surprises and Cash Flow. Such high marks indicate a dependable record of exceeding earnings expectations and maintaining substantial cash flow, both crucial for a thriving business. URS’s diversified portfolio ensures reduced risk, and consistent performance across various sectors further solidifies its stability.

    Relevance

    The company’s involvement in significant infrastructure projects and its diversified service portfolio suggest strong growth potential. For those interested in the engineering and construction services sector, URS Corp. stands out as a stable and promising investment.

    Analyst Ratings and Forecasts:

    Unfortunately, URS Corp. is a defunct company that was acquired by AECOM in 2014. Therefore, no current analyst ratings or forecasts are available for URS.

    However, if you’re interested in AECOM (ACM), the company that acquired URS, or similar companies in the industry, feel free to explore their financial evaluations and prospects based on the latest data.

    For more information, get Portfolio Grader’s complete analysis of URS stock

    These five stocks aren’t just names; they represent the future of multiple booming sectors. Backed by outstanding financial metrics and strong market positions, each of these companies presents a rich opportunity for growth. Use this information to seize the moment and make your move.

    * * *

    Is the World Saying Farewell to the iPhone?

    The iPhone has been Apple’s #1 product for over a decade…

    But it may not even exist as we know it by September 10.

    Here’s why

    * * *

    About Us
    About Us

    We're your inside source for the world's most profitable stock and investing ideas. We cut through the noise to bring you the high-conviction, market-moving information that can take your portfolio to the next level.

    Join thousands of individual investors who rely on Market Monitors to stay ahead of the game.

    Sign up for our free newsletter for our latest stock pick every morning before the market opens.

    Email Us: [email protected]

    Facebook X (Twitter) YouTube LinkedIn
    Our Picks

    The 5 Stocks Set To Dominate 2025

    May 28, 2025

    Top Graphene Stocks For 2025

    December 18, 2024

    Don’t Miss Out: These 5 Trump-Boosted Stocks Could Transform Your Portfolio!

    October 31, 2024
    Most Popular

    French Regulators Target Nvidia (NVDA): Could the AI Giant Be Broken Up?

    July 2, 2024

    Tesla (TSLA) Stumbles Amid Recalls, While Polestar (PSNY) Surges on New Launches

    July 2, 2024

    Investors Backing Off Eli Lilly (LLY): What’s Driving the Market Shift?

    July 2, 2024

    Type above and press Enter to search. Press Esc to cancel.